ABIVAX revenue and financials

ABVX · Euronext Paris · EUR

Compare ABIVAX
€75.50Change from previous close: −1.82%Absolute change: −€1.40

Close · November 17, 2026

In the fiscal year ended December 2025, ABIVAX reported revenue of €4.57M (−63.22% year over year). The net loss was €336.1M.

Annual revenue · 2025: €4.57M
  1. €151K2016
  2. €356K2017
  3. €815K2018
  4. €14K2020
  5. €4.2M2021
  6. €4.51M2022
  7. €4.57M2023
  8. €12.43M2024
  9. €4.57M2025

Fiscal year ending in December. Sources and method on the page How we analyse stocks.

At a glance

Revenue growth
−63.22%
2025 vs 2024
Net margin
-7,354.5%
2024: -1,418.3%

How ABIVAX is changing

Calculated from the annual statements; each fiscal year is labelled with the year it ends.

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

Income statement · Annual
Item2025202420232022202120202019201820172016
Total revenue4.612.44.64.54.20.0-0.00.80.40.2
Cost of revenue———50.845.533.828.215.410.514.6
Gross profit4.612.44.64.54.2-33.8-28.2-14.6-10.1-14.5
Selling, general and administrative72.938.928.87.55.65.64.94.33.83.6
Research and development17814710348.347.8—————
Operating income-246-173-127-51.2-49.1-39.6-33.3-19.1-14.2-18.2
EBIT-246-173-127-51.2-49.1-39.6-33.3-19.1-14.2-18.2
EBITDA-245-172-127-50.7-49.1-39.5-33.2-19.0-14.1-18.2
Interest expense28.512.413.86.93.62.31.60.50.00.0
Pre-tax income-330-176-148-60.7-42.5-40.1-34.9-19.8-13.9-17.8
Income tax5.80.00.00.0—-2.6-4.3-4.0-2.7-3.5
Net income-336-176-148-60.7-42.5-37.6-30.6-15.8-11.2-14.3
Net income to common shareholders-336-176-148-60.7-42.5-37.6-30.6-15.8-11.2-14.3
Basic EPS-4.83-2.80-3.43-3.18-2.75-2.62-2.51-1.55-1.13-1.47
Diluted EPS-4.83-2.80-3.43-3.18-2.75-2.62-2.51-1.55-1.13-1.47
Average shares (basic)69.563.043.119.115.514.312.210.29.99.7
Average shares (diluted)69.563.043.119.115.514.312.210.29.99.7

Companies in the group: same industry, similar size